Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So
Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So

Fosun leverages on pharmaceutical, biotech in race to tackle coronavirus as pandemic dents ClubMed, Cirque du Soleil units

  • Fosun plans to start clinical trials of its coronavirus vaccine called BNT162 from this month in race to find a cure
  • The group’s tourism and entertainment businesses are facing setbacks with shutdowns and lay-offs amid pandemic

Topic |   Fosun Group
Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So
Guo Guangchang, chairman and co-founder of Fosun International, speaks at a media briefing in March 2018. Photo: Edmond So
READ FULL ARTICLE